The Vertebroplasty and kyphoplasty Market size was valued at USD 0.75 Billion in 2022 and the total Vertebroplasty and kyphoplasty Market is expected to grow at a CAGR of 5.6% from 2023 to 2029, reaching nearly USD 1.3 Billion. Vertebroplasty and kyphoplasty are two minimally invasive surgical procedures used to treat painful vertebral compression fractures in the spine. Metroplasty involves injecting bone cement into a fractured vertebra through a small hole in the skin, which relieves pain caused by compression fractures, stabilizes the spine, and prevents further spinal dysfunction, thus improving the quality of life. On the other hand, kyphoplasty is a type of spinal augmentation procedure that relieves pain caused by a vertebral fracture, stabilizes the bone, and restores the height of the vertebral body, which is reduced due to compression fractures. In this procedure, a balloon is inserted and inflated to expand the compressed vertebrae to their normal height, and then bone cement is injected into the space. The increasing burden of vertebral compression fractures, rising geriatric population, and advancements in technology are the key factors driving the growth of the Vertebroplasty and Kyphoplasty market. Aging is the primary factor contributing to the Vertebroplasty and kyphoplasty growth, with the United Nations Department of Economics and Social 2022 report indicating that the global population aged 65 years or over reached 771 million in 2022. increasing product approvals and launches, as well as partnerships and collaborations by key players, increasing prevalence of urinary tract disorders in the elderly population and the rising incidence of vertebral compression fractures caused by osteoporosis, cancer, and other conditions are further driving the adoption of vertebroplasty, kyphoplasty, and other modern spine surgery procedures that aim to stabilize vertebral compression fractures, relieve pain, and restore spinal function.To know about the Research Methodology :- Request Free Sample Report
Competitive Landscapes:
The Vertebroplasty and Kyphoplasty Market is a highly competitive market, with the presence of several global and regional players. The competition is primarily based on the launch of new products in the market and the implementation of strategies to strengthen market positions. The players in the market are investing heavily in research and development to develop newer and more advanced devices that enable surgeons to perform the procedures with ease and enhance the healing process for patients. For instance, in October 2022, Halma announced the acquisition of IZI Medical Products, a leading designer, manufacturer, and distributor of medical devices used across a range of diagnostic and therapeutic procedures. IZI Medical Products offers vertebroplasty and kyphoplasty products such as DURO-JECT Bone Cement Injector Set, Vertefix HV High Viscosity Bone Cement, and Kiva VCF Treatment System, which further expands Halma's product portfolio.Similarly, in May 2021, Joimax and Trang Thi announced their partnership in bringing the Joimax full-endoscopic and minimally invasive spinal surgery technology to the Southern Provinces of Vietnam, including Da Nang market. This strategic move is expected to lead to a rise in sales of vertebroplasty and kyphoplasty products of Joimax in Vietnam. These initiatives are a reflection of the increasing trend among the players to expand their product portfolios and strengthen their market positions through strategic partnerships, collaborations, and acquisitions. The market is expected to witness intense industry rivalry during the forecast period, driven by the growing demand for vertebroplasty and kyphoplasty products in the region
Vertebroplasty and kyphoplasty Market Dynamics:
Increasing Incidence of Spinal Disorders Driving Market Growth of the Vertebroplasty and Kyphoplasty Market
The vertebroplasty and kyphoplasty market is driven by the increasing incidence of spinal disorders among the population due to various factors such as age, osteoporosis, and accidental injuries. Osteoporosis is a major factor that drives the market as it is expected to be responsible for three million fractures and result in a cost of $25.3 billion for the healthcare system by 2025 according to the National Osteoporosis Foundation. This highlights the rise in demand for vertebroplasty and kyphoplasty, propelling market growth during the forecast period. Accidental cases also lead to severe injuries, driving the vertebroplasty and kyphoplasty market further. For instance, in 2020, there were 3,66,138 road accidents in India, causing a loss of 1,31,714 lives and injuring 3,48,279 persons according to a report by the Ministry of Road Transport and Highways, Government of India. This increase in road accidents caused an increase in the incidence of spinal fractures and other spinal abnormalities, driving the vertebroplasty and kyphoplasty market. The rise in spinal disorders due to various factors has resulted in an increase in demand for vertebroplasty and kyphoplasty, especially in the treatment of osteoporosis and spinal fractures. This has led to an increase in the growth of the market in both developed and emerging economies during the forecast period.Advancements in Technology Driving Growth in the Vertebroplasty and Kyphoplasty Market Over the forecast period.
The vertebroplasty and kyphoplasty market is witnessing significant growth due to advancements in technology, especially in developed and emerging economies. Many global manufacturers with technical expertise and core competencies are constantly developing and manufacturing novel products to attract more customers. Improved biomaterial-based implants that offer high strength and prevent leaks of cement during fixation in spine fractures are experiencing an exponential rise in demand. Product developers in the field are focused on affordability, ease of utility, and novelty to cater to the increasing demand for affordable care among the rapidly growing population affected by spine fractures. The rise in preference for minimally invasive surgeries is boosting the demand for vertebroplasty and kyphoplasty procedures. The medical devices industry has also seen developments in the reconstruction of different equipment, such as the PVA Pod System by Crosstrees Medical, Inc., a novel bone cement delivery technology that does not require an implanted device in the spine. Since June 2018, Medtronic's Khphon bone cement has been available with a new indication for the use of sacral vertebral fracture. The increase in new applications of existing devices and the development of new devices are driving the utilization of vertebroplasty and kyphoplasty equipment in the healthcare industry, specifically for different surgeries of the spine.These technological advancements and improvements in vertebroplasty and kyphoplasty equipment have boosted the demand for the kyphoplasty procedure and vertebroplasty. As a result, the market is witnessing growth in developed as well as emerging economies, especially in the field of surgeryVertebroplasty and kyphoplasty Market Segment Analysis:
Based on Product Type
The global Vertebroplasty and Kyphoplasty market is segmented into vertebroplasty and kyphoplasty Devices. based on the product. In 2022, the kyphoplasty Devices segment dominated the global market share of Vertebroplasty and Kyphoplasty and is expected to remain dominant during the forecast period. The dominance of the kyphoplasty segment is mainly due to the advantages that it provides over vertebroplasty. For instance, kyphoplasty reduces back pain, restores vertebral body height, and has a lower rate of cement extravasation. Kyphoplasty achieves these benefits by gently elevating the fractured vertebrae using balloons to return them to their correct position. According to a study published in the Frontiers in Surgery Journal in July 2022, the use of kyphoplasty for the clinical treatment of various conditions such as osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion has increased globally due to the development of minimally invasive spinal surgery. Therefore, the rising adoption of kyphoplasty procedures for the treatment of vertebral compression fractures and cancers is expected to drive the growth of the kyphoplasty segment by increasing the adoption of kyphoplasty devices.By End User
The market is categorised into hospitals and ambulatory surgery centres. he hospital segment accounted for the largest market share in 2022 in the Vertebroplasty and Kyphoplasty market. This is mainly due to the better infrastructure facilities available in developed economies that make the hospital segment a more promising market. Additionally, vertebral compression fractures are responsible for approximately 70,000 hospitalizations annually in the United States, which is further supporting the growth of the market for Vertebroplasty and Kyphoplasty needles. The segment of ambulatory surgical centres (ASCs) is expected to witness the fastest compound annual growth rate (CAGR) over the forecast period in the industry. The primary reason for this is the low-cost advantage associated with ASCs. Surgeries performed in ASCs do not require hospital admission and hence provide cost-effective means for patients undergoing Vertebroplasty and Kyphoplasty procedures.Regional Insights:
The market for Vertebroplasty and Kyphoplasty is expected to witness significant growth in North America, mainly due to several factors such as the region's superior healthcare infrastructure, increasing government funding, greater awareness among healthcare industry stakeholders and the general public about available technologies, and a high concentration of market players in the region. These factors are expected to create a conducive environment for the growth of the for Vertebroplasty and Kyphoplasty market in North America. For instance, in September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health, enabling the company to develop its patented bone adhesive technology, Tetranite, for the treatment of vertebral compression fractures. The grant funding for the development of such technologies in vertebral compression fractures is expected to drive the growth of the market due to the increased launch and adoption of products in the market over the forecast period. The prevalence of osteoporosis in Canada is high, with more than 2.3 million Canadians living with the disease, and at least 1 in 3 women and 1 in 5 men experiencing an osteoporotic fracture during their lifetime, according to Osteoporosis Canada 2022. This high prevalence of osteoporosis in Canada is expected to increase the adoption of vertebroplasty and kyphoplasty procedures among the Canadian population, leading to a rise in the adoption of vertebroplasty and kyphoplasty devices and driving the industry growthVertebroplasty and kyphoplasty Market Scope: Inquiry Before Buying
Vertebroplasty and kyphoplasty Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: USD 0.75 Billion Forecast Period 2023 to 2029 CAGR: 5.6% Market Size in 2029: USD 1.3 Billion Segments Covered: by Product Type 1. kyphoplasty Devices 2. Vertebroplasty Devices by End User 1. Hospitals 2. Ambulatory Surgery Centers Global Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Vertebroplasty and kyphoplasty Key Players:
1. Medtronic 2. Alphatec Spine, Inc 3. Stryker 4. Merit Medical Systems 5. Globus Medical 6. IZI Medical Products 7. ZAVATION 8. RONTIS 9. G21 S.r.l. 10. SOMATEX Medical Technologies GmbH 11. BPB MEDICA 12. Laurane Medical LLC 13. Teknimed 14. Benvenue Medical 15. Spine Wave, Inc. 16. MEDAID Inc. 17. Cardinal Health 18. Joimax GmbHFAQs:
1] What segments are covered in the Global Vertebroplasty and kyphoplasty Market report? Ans. The segments covered in the Vertebroplasty and kyphoplasty report are based on Product Type, End User and region. 2] Which region is expected to hold the highest share in the Global Vertebroplasty and kyphoplasty Market during the forecast period? Ans. The North America region is expected to hold the highest share of the Vertebroplasty and kyphoplasty market during the forecast period. 3] What is the market size of the Global Vertebroplasty and kyphoplasty by 2029? Ans. The market size of the Vertebroplasty and kyphoplasty by 2029 is expected to reach US$ 1.3 Bn. 4] What is the forecast period for the Global Vertebroplasty and kyphoplasty Market? Ans. The forecast period for the Vertebroplasty and kyphoplasty market is 2023-2029. 5] What was the market size of the Global Vertebroplasty and kyphoplasty in 2021? Ans. The market size of the Vertebroplasty and kyphoplasty in 2022 was valued at US$ 0.71 Bn.
1. Vertebroplasty and kyphoplasty Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Vertebroplasty and kyphoplasty Market: Dynamics 2.1. Vertebroplasty and kyphoplasty Market Trends by Region 2.1.1. North America Vertebroplasty and kyphoplasty Market Trends 2.1.2. Europe Vertebroplasty and kyphoplasty Market Trends 2.1.3. Asia Pacific Vertebroplasty and kyphoplasty Market Trends 2.1.4. Middle East and Africa Vertebroplasty and kyphoplasty Market Trends 2.1.5. South America Vertebroplasty and kyphoplasty Market Trends 2.2. Vertebroplasty and kyphoplasty Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Vertebroplasty and kyphoplasty Market Drivers 2.2.1.2. North America Vertebroplasty and kyphoplasty Market Restraints 2.2.1.3. North America Vertebroplasty and kyphoplasty Market Opportunities 2.2.1.4. North America Vertebroplasty and kyphoplasty Market Challenges 2.2.2. Europe 2.2.2.1. Europe Vertebroplasty and kyphoplasty Market Drivers 2.2.2.2. Europe Vertebroplasty and kyphoplasty Market Restraints 2.2.2.3. Europe Vertebroplasty and kyphoplasty Market Opportunities 2.2.2.4. Europe Vertebroplasty and kyphoplasty Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Vertebroplasty and kyphoplasty Market Drivers 2.2.3.2. Asia Pacific Vertebroplasty and kyphoplasty Market Restraints 2.2.3.3. Asia Pacific Vertebroplasty and kyphoplasty Market Opportunities 2.2.3.4. Asia Pacific Vertebroplasty and kyphoplasty Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Vertebroplasty and kyphoplasty Market Drivers 2.2.4.2. Middle East and Africa Vertebroplasty and kyphoplasty Market Restraints 2.2.4.3. Middle East and Africa Vertebroplasty and kyphoplasty Market Opportunities 2.2.4.4. Middle East and Africa Vertebroplasty and kyphoplasty Market Challenges 2.2.5. South America 2.2.5.1. South America Vertebroplasty and kyphoplasty Market Drivers 2.2.5.2. South America Vertebroplasty and kyphoplasty Market Restraints 2.2.5.3. South America Vertebroplasty and kyphoplasty Market Opportunities 2.2.5.4. South America Vertebroplasty and kyphoplasty Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Vertebroplasty and kyphoplasty Industry 2.8. Analysis of Government Schemes and Initiatives For Vertebroplasty and kyphoplasty Industry 2.9. Vertebroplasty and kyphoplasty Market Trade Analysis 2.10. The Global Pandemic Impact on Vertebroplasty and kyphoplasty Market 3. Vertebroplasty and kyphoplasty Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 3.1.1. kyphoplasty Devices 3.1.2. Vertebroplasty Devices 3.2. Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 3.2.1. Hospitals 3.2.2. Ambulatory Surgery Centers 3.3. Vertebroplasty and kyphoplasty Market Size and Forecast, by Region (2022-2029) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Vertebroplasty and kyphoplasty Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 4.1.1. kyphoplasty Devices 4.1.2. Vertebroplasty Devices 4.2. North America Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 4.2.1. Hospitals 4.2.2. Ambulatory Surgery Centers 4.3. North America Vertebroplasty and kyphoplasty Market Size and Forecast, by Country (2022-2029) 4.3.1. United States 4.3.1.1. United States Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 4.3.1.1.1. kyphoplasty Devices 4.3.1.1.2. Vertebroplasty Devices 4.3.1.2. United States Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 4.3.1.2.1. Hospitals 4.3.1.2.2. Ambulatory Surgery Centers 4.7.2. Canada 4.3.2.1. Canada Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 4.3.2.1.1. kyphoplasty Devices 4.3.2.1.2. Vertebroplasty Devices 4.3.2.2. Canada Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 4.3.2.2.1. Hospitals 4.3.2.2.2. Ambulatory Surgery Centers 4.7.3. Mexico 4.3.3.1. Mexico Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 4.3.3.1.1. kyphoplasty Devices 4.3.3.1.2. Vertebroplasty Devices 4.3.3.2. Mexico Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 4.3.3.2.1. Hospitals 4.3.3.2.2. Ambulatory Surgery Centers 5. Europe Vertebroplasty and kyphoplasty Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.2. Europe Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3. Europe Vertebroplasty and kyphoplasty Market Size and Forecast, by Country (2022-2029) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.1.2. United Kingdom Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.2. France 5.3.2.1. France Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.2.2. France Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.3. Germany 5.3.3.1. Germany Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.3.2. Germany Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.4. Italy 5.3.4.1. Italy Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.4.2. Italy Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.5. Spain 5.3.5.1. Spain Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.5.2. Spain Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.6. Sweden 5.3.6.1. Sweden Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.6.2. Sweden Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.7. Austria 5.3.7.1. Austria Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.7.2. Austria Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 5.3.8.2. Rest of Europe Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.2. Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.7. Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast, by Country (2022-2029) 6.3.1. China 6.3.1.1. China Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.1.2. China Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.2. S Korea 6.3.2.1. S Korea Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.2.2. S Korea Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.3. Japan 6.3.3.1. Japan Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.3.2. Japan Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.4. India 6.3.4.1. India Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.4.2. India Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.5. Australia 6.3.5.1. Australia Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.5.2. Australia Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.6. Indonesia 6.3.6.1. Indonesia Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.6.2. Indonesia Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.7. Malaysia 6.3.7.1. Malaysia Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.7.2. Malaysia Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.8. Vietnam 6.3.8.1. Vietnam Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.8.2. Vietnam Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.9. Taiwan 6.3.9.1. Taiwan Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.9.2. Taiwan Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 6.3.10.2. Rest of Asia Pacific Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa Vertebroplasty and kyphoplasty Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 7.2. Middle East and Africa Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 7.7. Middle East and Africa Vertebroplasty and kyphoplasty Market Size and Forecast, by Country (2022-2029) 7.7.1. South Africa 7.3.1.1. South Africa Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 7.3.1.2. South Africa Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 7.7.2. GCC 7.3.2.1. GCC Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 7.3.2.2. GCC Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 7.7.3. Nigeria 7.3.3.1. Nigeria Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 7.3.3.2. Nigeria Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 7.3.4.2. Rest of ME&A Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 8. South America Vertebroplasty and kyphoplasty Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 8.2. South America Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 8.7. South America Vertebroplasty and kyphoplasty Market Size and Forecast, by Country (2022-2029) 8.3.1. Brazil 8.3.1.1. Brazil Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 8.3.1.2. Brazil Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 8.3.2. Argentina 8.3.2.1. Argentina Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 8.3.2.2. Argentina Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Vertebroplasty and kyphoplasty Market Size and Forecast, by Product Type (2022-2029) 8.3.3.2. Rest Of South America Vertebroplasty and kyphoplasty Market Size and Forecast, by End User (2022-2029) 9. Global Vertebroplasty and kyphoplasty Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Vertebroplasty and kyphoplasty Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Medtronic 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Alphatec Spine, Inc 10.3. Stryker 10.4. Merit Medical Systems 10.5. Globus Medical 10.6. IZI Medical Products 10.7. ZAVATION 10.8. RONTIS 10.9. G21 S.r.l. 10.10. SOMATEX Medical Technologies GmbH 10.11. BPB MEDICA 10.12. Laurane Medical LLC 10.13. Teknimed 10.14. Benvenue Medical 10.15. Spine Wave, Inc. 10.16. MEDAID Inc. 10.17. Cardinal Health 10.18. Joimax GmbH 11. Key Findings 12. Industry Recommendations 13. Vertebroplasty and kyphoplasty Market: Research Methodology 14. Terms and Glossary